Recent studies have indicated that plasma adiponectin levels are reduced in obese and type 2 diabetic patients [13], and adiponectin administration improved insulin resistance in diabetic mice [14, 15]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.